In a 23‑year‑old woman with 12 kg weight loss over 5 months, intermittent dizziness, systolic hypotension (98 mm Hg), normal routine labs, low‑normal 8 am serum cortisol (6 µg/dL) and eosinophilia (~1200/µL), could this be primary adrenal insufficiency (Addison’s disease)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 27, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Suspected Primary Adrenal Insufficiency (Addison's Disease)

Direct Recommendation

Your clinical suspicion is well‑founded: proceed immediately with a cosyntropin stimulation test to confirm primary adrenal insufficiency, and do not delay endocrinology referral. 1


Why This Clinical Picture Strongly Suggests Addison's Disease

Your patient presents with a classic constellation for primary adrenal insufficiency:

  • Significant unintentional weight loss (12 kg over 5 months) is a hallmark feature of chronic glucocorticoid and mineralocorticoid deficiency 2, 3
  • Intermittent dizziness with systolic hypotension (98 mm Hg) reflects orthostatic hypotension from mineralocorticoid deficiency 2, 3
  • Low‑normal 8 AM cortisol (6 µg/dL ≈ 165 nmol/L) is below the threshold that excludes adrenal insufficiency (>550 nmol/L or >18–20 µg/dL rules it out) and falls into the indeterminate zone requiring dynamic testing 1
  • Eosinophilia (~1200/µL, 9%) is a recognized laboratory finding in adrenal insufficiency, though not always present 1

Critical point: A morning cortisol of 6 µg/dL is neither diagnostic nor reassuring—it sits in the gray zone where cosyntropin stimulation testing is mandatory 1.


Diagnostic Confirmation: Cosyntropin Stimulation Test

Protocol

  • Administer 0.25 mg (250 µg) cosyntropin intravenously or intramuscularly 1
  • Measure serum cortisol at baseline, 30 minutes, and optionally 60 minutes post‑administration 1
  • Obtain a baseline plasma ACTH before cosyntropin administration to distinguish primary from secondary adrenal insufficiency 1

Interpretation

  • Peak cortisol <500 nmol/L (<18 µg/dL) at 30 or 60 minutes confirms adrenal insufficiency 1
  • Peak cortisol >550 nmol/L (>18–20 µg/dL) excludes the diagnosis 1
  • Markedly elevated ACTH (>300 pg/mL) with low cortisol establishes primary adrenal insufficiency without further testing 1

Etiologic Workup After Biochemical Confirmation

First‑Line: Autoimmune Screening

  • Measure 21‑hydroxylase autoantibodies—positive in ~85% of autoimmune Addison's disease in Western populations 1, 3, 4
  • If positive, no further etiologic investigation is needed 1

If Autoantibodies Are Negative

  • Obtain contrast‑enhanced CT scan of the adrenal glands to assess for hemorrhage, tuberculosis, metastatic disease, or infiltrative processes 1
  • In males, measure very‑long‑chain fatty acids to screen for X‑linked adrenoleukodystrophy 1

Critical Management Considerations

If the Patient Becomes Acutely Unwell

Never delay treatment for diagnostic procedures if adrenal crisis is suspected (e.g., worsening hypotension, severe vomiting, altered mental status, collapse) 1:

  • Administer 100 mg IV hydrocortisone immediately 1, 5
  • Infuse 0.9% saline at 1 L/hour (at least 2 L total) 1, 5
  • Draw blood for cortisol and ACTH before steroid administration if feasible, but do not wait for results 1

Common Diagnostic Pitfalls to Avoid

  • Do not rely on the absence of hyperkalemia to exclude primary adrenal insufficiency—it is present in only ~50% of cases 1
  • Do not rely on the absence of hyperpigmentation—it develops gradually and may not yet be evident in early or subacute presentations 1
  • Do not assume normal electrolytes rule out the diagnosis—10–20% of patients have normal sodium and potassium at presentation 1

Lifelong Treatment Once Diagnosis Is Confirmed

Glucocorticoid Replacement

  • Hydrocortisone 15–25 mg daily in divided doses (e.g., 10 mg at 07:00,5 mg at 12:00,2.5–5 mg at 16:00) 6, 5
  • Alternative: cortisone acetate 25–37.5 mg daily or prednisone 4–5 mg daily 6, 5

Mineralocorticoid Replacement (Primary AI Only)

  • Fludrocortisone 50–200 µg once daily upon awakening 6, 5
  • Monitor adequacy by assessing salt cravings, orthostatic blood pressure, peripheral edema, and plasma renin activity 6, 5

Patient Education and Safety Measures

  • Double or triple glucocorticoid dose during minor illness, fever, or physical stress 5
  • Prescribe an emergency injectable hydrocortisone 100 mg IM kit with self‑injection training 5
  • Ensure the patient wears a medical alert bracelet indicating adrenal insufficiency 5

Stress Dosing for Surgery

  • Major surgery: hydrocortisone 100 mg IM before anesthesia, then 100 mg IM every 6 hours until oral intake resumes 6, 5

Annual Monitoring and Screening for Associated Autoimmune Conditions

  • Assess symptoms, weight, blood pressure, serum sodium, potassium, glucose, and HbA1c 5
  • Screen thyroid function tests and vitamin B12 levels annually, as autoimmune adrenalitis frequently coexists with other autoimmune disorders 5, 3
  • Screen for celiac disease (tissue transglutaminase antibodies) if the patient has episodic diarrhea 1

Why Endocrinology Referral Is Essential

  • Confirmation of the diagnosis requires specialized dynamic testing and interpretation 1
  • Lifelong hormone replacement demands expert dose titration and stress‑dosing protocols 5
  • Patients with newly diagnosed adrenal insufficiency require comprehensive education on crisis prevention and emergency management 5

References

Guideline

Diagnosing Adrenal Insufficiency in Hypo-osmolar Hyponatremia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Addison's disease.

Clinics in dermatology, 2006

Guideline

Adrenal Insufficiency Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.